000 | 01980 a2200529 4500 | ||
---|---|---|---|
005 | 20250515110828.0 | ||
264 | 0 | _c20080613 | |
008 | 200806s 0 0 eng d | ||
022 | _a1473-4877 | ||
024 | 7 |
_a10.1185/030079908x280464 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDuh, Mei Sheng | |
245 | 0 | 0 |
_aCosts associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis. _h[electronic resource] |
260 |
_bCurrent medical research and opinion _cApr 2008 |
||
300 |
_a967-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Care Costs |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfusions, Intravenous _xeconomics |
650 | 0 | 4 | _aInsurance Claim Review |
650 | 0 | 4 | _aIrinotecan |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aReynolds Weiner, Jennifer | |
700 | 1 | _aLefebvre, Patrick | |
700 | 1 | _aNeary, Maureen | |
700 | 1 | _aSkarin, Arthur T | |
773 | 0 |
_tCurrent medical research and opinion _gvol. 24 _gno. 4 _gp. 967-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1185/030079908x280464 _zAvailable from publisher's website |
999 |
_c17786833 _d17786833 |